Note that these results probably apply to Mounjaro/Zepbound as well, because they are the most effective GLP1s on the market right now: https://glp1.guide/cont

Note that these results probably apply to Mounjaro/Zepbound as well, because they are the most effective GLP1s on the market right now: https://glp1.guide/content/semaglutide-vs-tirzepatide-clinical-trial/ https://glp1.guide/content/semaglutide-vs-tirzepatide-clinic... My bet is on the reduction in inflammation -- it's a notoriously beneficial positive side effect of GLP1 Receptor Agonists, along with the obvious reduction in weight or HbA1c.